Haisco Pharmaceutical Group Co Ltd (002653)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Haisco Pharmaceutical Group Co Ltd (002653) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014240
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Haisco Pharmaceutical Group Co Ltd (Haisco Pharma), formerly Xizang Haisco Pharmaceutical Group Co Ltd is a developer and marketer of chemical drug preparations and bulk drugs. The company’s product portfolio comprises injection for trace elements, compound vitamin, invert sugar, fat soluble vitamins, long-chain fat emulsion, compound amino acid among others. Its products include parenteral nutrition drugs, first-aid drugs, antibiotics, anesthetic agents, nervous system drugs, digestive system drugs and tumor adjuvant drugs. It conducts research and development of drugs in monoclonal antibodies for anticancer, small molecular patent medicine and novel generic drugs. Haisco Pharma is headquartered in Shannan, China.

Haisco Pharmaceutical Group Co Ltd (002653) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Haisco Pharmaceutical Group Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 11
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 12
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 13
Hinova Pharma and Sichuan Haisco Pharma Enter into Agreement 14
Microbion Enters into Agreement with Xizang Haisco Pharma 15
Equity Offering 16
Microbion Raises Funds through Private Placement of Shares 16
Xizang Haisco Pharma Completes IPO For US$127 Million 17
Debt Offering 18
Xizang Haisco Pharma Raises USD29 Million in Public Offering of 5.38% Notes 18
Acquisition 19
Liaoning Haisco Pharma to Acquire Shenyang Haisco Pharma for USD14.5 Million 19
Haisco Pharmaceutical Group Co Ltd – Key Competitors 20
Haisco Pharmaceutical Group Co Ltd – Key Employees 21
Haisco Pharmaceutical Group Co Ltd – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Haisco Pharmaceutical Group Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Haisco Pharmaceutical Group Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Haisco Pharmaceutical Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 11
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 12
Haisco Pharma Enters into Drug Development Agreement with Anxo Pharma 13
Hinova Pharma and Sichuan Haisco Pharma Enter into Agreement 14
Microbion Enters into Agreement with Xizang Haisco Pharma 15
Microbion Raises Funds through Private Placement of Shares 16
Xizang Haisco Pharma Completes IPO For US$127 Million 17
Xizang Haisco Pharma Raises USD29 Million in Public Offering of 5.38% Notes 18
Liaoning Haisco Pharma to Acquire Shenyang Haisco Pharma for USD14.5 Million 19
Haisco Pharmaceutical Group Co Ltd, Key Competitors 20
Haisco Pharmaceutical Group Co Ltd, Key Employees 21
Haisco Pharmaceutical Group Co Ltd, Other Locations 22
Haisco Pharmaceutical Group Co Ltd, Subsidiaries 22

★海外企業調査レポート[Haisco Pharmaceutical Group Co Ltd (002653)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mycenax Biotech Inc (4726):製薬・医療:M&Aディール及び事業提携情報
    Summary Mycenax Biotech Inc (Mycenax) is a biopharmaceutical company that develops and manufactures pharmaceutical formulations. The company provides pipeline portfolio encompasses investigational candidates targeted at the treatment of plaque psoriasis, glioblastoma, asthma, adult crohn's Disease, …
  • Hung Hing Printing Group Limited:企業の戦略・SWOT・財務情報
    Hung Hing Printing Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hung Hing Printing Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Shamrock Foods Company:企業の戦略的SWOT分析
    Shamrock Foods Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • China Southern Airlines Company Limited:戦略・SWOT・企業財務分析
    China Southern Airlines Company Limited - Strategy, SWOT and Corporate Finance Report Summary China Southern Airlines Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Oldenburgische Landesbank AG:企業の戦略・SWOT・財務分析
    Oldenburgische Landesbank AG - Strategy, SWOT and Corporate Finance Report Summary Oldenburgische Landesbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • NovaBay Pharmaceuticals Inc (NBY):医療機器:M&Aディール及び事業提携情報
    Summary NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that discovers and develops eyecare products. The company’s products include skin and wound cleanser, daily lid and lash hygiene spray solutions, and cosetic procedures. Its daily lid a …
  • Mediolanum farmaceutici SpA-製薬・医療分野:企業M&A・提携分析
    Summary Mediolanum farmaceutici SpA (Mediolanum) is a healthcare solution provider that discovers, develops and markets pharmaceuticals products and prescription drugs. The company offers products in therapeutic areas which include neuropsychiatric, osteoarticular, antibiotic, pneumoallergological, …
  • Personal Genome Diagnostics Inc:製品パイプライン分析
    Summary Personal Genome Diagnostics Inc (PGD) is a genomic solution provider. The company develops next-generation sequencing and proprietary algorithms to identify alterations in complex cancer genomes. It provides a portfolio of regulated tissue-based and liquid biopsy genomic products for laborat …
  • Daniel Thwaites Plc:戦略・SWOT・企業財務分析
    Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report Summary Daniel Thwaites Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Petroliam Nasional Berhad:企業の戦略・SWOT・財務情報
    Petroliam Nasional Berhad - Strategy, SWOT and Corporate Finance Report Summary Petroliam Nasional Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Mendor Oy-製薬・医療分野:企業M&A・提携分析
    Summary Mendor Oy (Mendor) is a medical equipment company that designs, develops and markets advanced diabetes management products. The company’s products include portable blood glucose meter and web-based software application for the daily management of diabetes. It offers blood glucose meter mendo …
  • Emerson Electric Co (EMR):石油・ガス:M&Aディール及び事業提携情報
    Summary Emerson Electric Co. (Emerson) is a provider of infrastructure technologies and life cycle services for information and communication technology systems. The company offers hardware and software solutions for power, thermal and infrastructure management under the brands of Kop-Flex, jaure, a …
  • ComfortDelGro Corporation Limited:戦略・SWOT・企業財務分析
    ComfortDelGro Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary ComfortDelGro Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Kao Corporation:企業の戦略・SWOT・財務情報
    Kao Corporation - Strategy, SWOT and Corporate Finance Report Summary Kao Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Drugs for Neglected Diseases initiative-製薬・医療分野:企業M&A・提携分析
    Summary Drugs for Neglected Diseases initiative (DNDi) is a research center that discovers and develops new drugs. The center develops therapeutics for the treatment of various diseases. It offers treatments which include ASAQ, ASMQ, NECT, SSG&PM and pediatric benznidazole. DNDi also offers products …
  • GenapSys Inc:医療機器:M&Aディール及び事業提携情報
    Summary GenapSys Inc (GenapSys) is engaged in the development of DNA sequencing technologies for applied genomic testing, and medical sequencing. The company offers a Gene Electronic Nano-Integrated Ultra-Sensitive (GENIUS) technology platform that identifies the genome and delivers the insights of …
  • Bukwang Pharm Co Ltd (003000):製薬・医療:M&Aディール及び事業提携情報
    Summary Bukwang Pharm Co Ltd (Bukwang Pharmaceutical) is a pharmaceutical company that develops new drugs and pharmaceutical products. The company’s products portfolio includes dexid, thioctacid, levovir, legalon, Orfil, azeptin, lonasen, ixel, and asima, among others. Its pipeline products comprise …
  • Nexira:戦略・SWOT・企業財務分析
    Nexira - Strategy, SWOT and Corporate Finance Report Summary Nexira - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Development Bank of Southern Africa-エネルギー分野:企業M&A・提携分析
    Summary Development Bank of Southern Africa (DBSA) offers various leading and infrastructure development financial services. Its service offering includes debt limited non-recourse lending, mezzanine finance, and promotion of inter-regional integration and co-operation. It offers implementation serv …
  • Kenra Professional, LLC:企業の戦略・SWOT・財務分析
    Kenra Professional, LLC - Strategy, SWOT and Corporate Finance Report Summary Kenra Professional, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆